PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.115541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Ben Zhao und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Bridge Institute…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins, Carcinoma, Pancreatic Ductal, Cell Cycle Proteins, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Cancer Consortium, Deutsche Krebshilfe, Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Bridge Institute of Experimental Tumor Therapy (BIT) and Division of Solid Tumor Trans…
- Bridge Institute of Experimental Tumor Therapy (BIT) and Division of Solid Tumor Translational Oncology (DKTK), West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany; G…
- German Cancer Consortium (DKTK), partner site Essen, a partnership between German Cancer Research Center (DKFZ) and University Hospital Essen, 45147 Essen, Germany; Department of Medical Oncology, West German Cancer Cen…
- Department of Molecular GI Oncology, Faculty of Medicine, Ruhr University Bochum, 44780 Bochum, Germany; Department of Internal Medicine, Ruhr University Bochum, Knappschaftskrankenhaus, 44780 Bochum, Germany.
- Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, 40225 Düsseldorf, Germany; Department of Laboratory Medicine and Pathobiology, University of Toront…
Förderung
- German Cancer Consortium
- Deutsche Krebshilfe
- Bundesministerium für Bildung und Forschung
- Deutsche Forschungsgemeinschaft
- Federal Ministry of Education and Research Berlin Office
- Hubei Province Natural Science Foundation
Zitieren
APA
Zhao, B., Fang, R., Schürmann, H., Hemmer, E. J., Mayer, G. L., Trajkovic-Arsic, M., Althoff, K., Yang, J., Godfrey, L., Liffers, S. T., Savvatakis, K., Dorsch, M., Grüner, B. M., Hahn, S., Remke, M., Lueong, S. S., & Siveke, J. T. (2025). PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115541
Vancouver
Zhao B, Fang R, Schürmann H, Hemmer EJ, Mayer GL, Trajkovic-Arsic M, et al. PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115541
BibTeX
@article{Zhao2025,
author = {Zhao, Ben and Fang, Rui and Schürmann, Hendrik and Hemmer, Erik Jan and Mayer, Gina Lauren and Trajkovic-Arsic, Marija and Althoff, Kristina and Yang, Jiajin and Godfrey, Laura and Liffers, Sven T and Savvatakis, Konstantinos and Dorsch, Madeleine and Grüner, Barbara M and Hahn, Stephan and Remke, Marc and Lueong, Smiths S and Siveke, Jens T},
title = {PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.115541}
}
EUVIMED